The second largest health insurer in Massachusetts has announced that it will no longer cover specialty medications known as compounded drugs, months after a deadly nationwide meningitis outbreak was traced to a Massachusetts compounding pharmacy.
The chief medical officer at Harvard Pilgrim Health Care says the policy stems from a safety review after the meningitis outbreak traced to tainted steroids produced at New England Compounding Center in Framingham that killed 58.
Dr. Michael Sherman tells The Boston Globe that most of the insurance claims it received from patients for compounded drugs were for medications that should not be covered by a health insurer.
The coverage ends Aug. 7, but Harvard Pilgrim will consider appeals on a case by case basis.
The decision drew fire from pharmacists and patient advocates.
Topics Carriers Massachusetts
Was this article valuable?
Here are more articles you may enjoy.
Iran’s Grip on Hormuz Is Tighter Than Ever After a Month of War 
Giuliani Fails to Get $10 Million Sexual Harassment Suit in New York Dismissed 
Viewpoint: California’s Surplus Lines HO Market Driven by Access, Not Wildfire Risk 
Axios Software Tool Used by Millions Compromised in Hack 
